Fuso’s Ordinary and Net Losses were Pushed into Deficit by Quake (April-September 2011)

Shokichi Nishimura of Fuso at the Company Earnings Announcement According to its consolidated settlement of accounts for April-September 2011 announced on November 9, Fuso Pharmaceutical Industries’ sales declined to ¥21.644 billion (-10.1% compared to the corresponding period of the previous...read more